Cargando…
Multiple drugs: Alloantibodies development, pregnancy exposure and off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933160/ http://dx.doi.org/10.1007/s40278-022-11854-2 |
Ejemplares similares
-
Multiple drugs: Lack of efficacy, off label use and exposure during pregnancy: case report
Publicado: (2022) -
Multiple drugs: QTc prolongation, hyperglycaemia, off label use and drug exposure during pregnancy: case report
Publicado: (2021) -
Multiple drugs: Lack of efficacy, off-label use and exposure during pregnancy: 3 case reports
Publicado: (2022) -
Hemolytic disease of the fetus and newborn due to multiple alloantibodies in pregnancy
por: Gupta, Vidushi, et al.
Publicado: (2020) -
Multiple drugs: Euglycaemic diabetic ketoacidosis, lack of efficacy and off-label use following exposure during pregnancy: case report
Publicado: (2022)